ArticleTranslational cancer research2025

Construction of a novel disulfidptosis-associated lncRNAs signature for risk features and immunotherapy in breast cancer.

Jun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.